Organization: Biotechnology Research Institute

AstraZeneca buys DSM’s Montreal facility

AstraZeneca has acquired the mothballed Montreal biologics manufacturing facility from DSM Biologics Inc — the second major investment the UK-based pharmaceutical firm has made in Montreal this year. AstraZeneca will begin re-commissioning the facility immediately and expects to begin full-scale production in 2009. Located adjacent to the National Research Council‘s Biotechnology Research Institute, it will…

McGill Univ’s health research institute moves to BRI

The research institute encompassing McGill Univ‘s five teaching hospitals is moving into the National Research Council‘s Biotechnology Research Institute (BRI). The agreement between BRI and the Research Institute of the McGill University Health Centre (RI-MUHC) is being hailed as a first between a university and a federal agency. RI-MUHC will benefit from BRI’s modern facilities…

ProMetic strikes Brazilian licensing deal

Montreal’s ProMetic Life Sciences Inc has entered into a technology transfer and licensing agreement with Brazil’s Tecpar for the manufacture of a complex biopharmaceutical product for the South American market. The agreement combines a proprietary manufacturing process licensed from the National Research Council‘s Biotechnology Research Institute and ProMetic’s bioseparation process using Mimetic Legand technology. Prometic…

Laborium signs pact with NRC’s BRI

Laborium Biopharma Inc and the National Research Council’s Biotechnology Research Institute (BRI) have entered a strategic alliance to provide services for the manufacturing and packaging of clinical lots of biological products according to cGMP standards. The alliance is part of a larger initiative to develop a cGMP biomanufacturing and training centre around BRI expertise and…